- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Susan Escudier: OCM Improvements That Practices Should Continue
Even though the Oncology Care Model (OCM) ended on June 30, 2022, there are some improvements that practices should continue implementing, said Susan Escudier, MD, FACP, vice president of value-based care and quality programs, Texas Oncology.
Even though the Oncology Care Model (OCM) ended on June 30, 2022, there are some improvements that practices should continue implementing, said Susan Escudier, MD, FACP, vice president of value-based care and quality programs, Texas Oncology.
Note: This interview took place prior to the June 30, 2022, end of the OCM.
Transcript
What do you hope or expect practices will continue to do even after the OCM ends?
I think the things, to me, that were important: I like our standardized treatment plans. I find them to be a nice teaching tool for the patient to explain their diagnosis, their prognosis. I hand it to them. I hand them a drug handout. They go home, they share it with their family. It's a nice way for them to be able to go home and study the information and think about it. Also, sometimes they forget what we tell them, so it’s helpful for that aspect.
I think the patient outreach—like calling patients after treatments—I think that should stick around. I think one of our big wins was being able to cut the turnaround time on getting patient calls answered. I think that's a big win we need to keep.
I think there are a lot of improvements that were made—our depression screenings, our distress screenings increased—and those are things we really need to keep doing going forward.
What Will AI in Health Care Look Like in the Future?
July 10th 2025Artificial intelligence (AI) transforms oncology by enhancing clinical decision-making, improving patient outcomes, and shaping future health care training, as discussed by experts at Tennessee Oncology's “Tech Innovations in Community Oncology."
Read More
Using AI for the Medical Note: Game Changer or a Bridge Too Far?
July 9th 2025During the “Tech Innovations in Community Oncology” meeting from Tennessee Oncology, oncologists explore artificial intelligence (AI) tools like DeepScribe to enhance documentation efficiency, reduce burnout, and improve patient engagement in clinical settings.
Read More
Driving Value via Outcomes-Based Pricing and EHR Interoperability: Tyler Sandahl, PharmD
July 7th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, discussed the complexities of alternative payment models for chimeric antigen receptor T-cell and bispecific therapies and the need for improved data sharing in cancer care.
Read More
At ASCO, Testing and AI Rival Drugs for Attention, but Reimbursement Remains a Barrier
July 5th 2025Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage cancer care over time. A feature from our upcoming special issue of Evidence-Based Oncology: our annual ASCO recap.
Read More
